Conditions: Acute Myeloid Leukemia (AML) Myelodysplastic Syndrome
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 12
Healthy volunteers: no

Brief summary:
The study tests the safety and efficacy of axitinib in patients who have the hematologic disease of Acute Myeloid Leukemia or Myelodysplastic Syndrome. The study tests patients who have poor prognosis before entering the study.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: AG-013736 (Axitinib)
Intervention descriptions: intervention 1: patients were treated with axitinib at starting dose of 5 mg BID continuous dosing.

Protocol document: